Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.

× No keyword cloud information.

24 in total

Review 1. The activity of azithromycin in animal models of infection.

Authors: J C Pechère
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-10 Impact factor: 3.267

Review 2. Antimycobacterial susceptibility testing: present practices and future trends.

Authors: C B Inderlied
Journal: Eur J Clin Microbiol Infect Dis Date: 1994-11 Impact factor: 3.267

3. Stimulation with cytokines enhances penetration of azithromycin into human macrophages.

Authors: L E Bermudez; C Inderlied; L S Young
Journal: Antimicrob Agents Chemother Date: 1991-12 Impact factor: 5.191

Review 4. Spectrum of activity of azithromycin.

Authors: J D Williams
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-10 Impact factor: 3.267

5. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.

Authors: Luiz E Bermudez; Peter Kolonoski; Lianne E Seitz; Mary Petrofsky; Robert Reynolds; Martin Wu; Lowell S Young
Journal: Antimicrob Agents Chemother Date: 2004-09 Impact factor: 5.191

6. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.

Authors: L E Bermudez; P Kolonoski; L S Young
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191

7. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.

Authors: L E Bermudez; C B Inderlied; P Kolonoski; M Wu; L Barbara-Burnham; L S Young
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

8. Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.

Authors: L E Bermudez; C B Inderlied; P Kolonoski; M Petrofsky; L S Young
Journal: Antimicrob Agents Chemother Date: 1994-12 Impact factor: 5.191

9. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.

Authors: C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

Review 10. The Mycobacterium avium complex.

Authors: C B Inderlied; C A Kemper; L E Bermudez
Journal: Clin Microbiol Rev Date: 1993-07 Impact factor: 26.132